Scarborough Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-304
Closed -$26.3K 453
2026
Q1
$26.3K Buy
304
+57
+23% +$5.46K ﹤0.01% 311
2025
Q4
$23.7K Buy
247
+191
+341% +$18.6K ﹤0.01% 189
2025
Q3
$5.33K Hold
56
﹤0.01% 305
2025
Q2
$4.88K Buy
+56
New +$4.75K ﹤0.01% 301
2024
Q3
Sell
-4
Closed -$315 305
2024
Q2
$315 Buy
+4
New +$328 ﹤0.01% 385
2024
Q1
Sell
-54
Closed -$4.45K 590
2023
Q4
$4.45K Buy
+54
New +$4.12K ﹤0.01% 487

Other funds holding MDT

Scarborough Advisors's MDT Position: Q2 2026 in Review

Scarborough Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 304 shares — an estimated $26.3K sold.

Scarborough Advisors first reported a position in MDT in Q4 2023 and held it in 6 quarters. The position peaked at $26.3K in Q1 2026. 2,124 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Scarborough Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Scarborough Advisors sold 304 Medtronic shares in Q2 2026, an estimated $26.3K.
  • Scarborough Advisors first reported a position in Medtronic in Q4 2023 and held it in 6 quarters.
  • Scarborough Advisors's Medtronic position peaked at $26.3K in Q1 2026.
  • 2,124 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.